Zhongshan Hospital Xiamen University
Key facts
Zhongshan Hospital Xiamen University is a public hospital in Xiamen, China. Its hospital grade in our sources is 3A. International patients are served by its International Medical Center (IMC). Primary contact: +86 592 229 2266 (IMC 24-hour hotline).
- City: Xiamen
- Type: Public hospital
- Grade: 3A
- International desk: International Medical Center (IMC)
- Primary contact: +86 592 229 2266 (IMC 24-hour hotline)
- Last verified:
Zhongshan Hospital Xiamen University, founded in 1928, is a Grade 3A general hospital in Siming with four national key clinical specialties including General Surgery, Orthopedics and Gastroenterology. Its International Medical Center opened in June 2025 with a 24-hour reception hotline, outpatient rooms, a check-up center and dedicated wards. The hospital's commercial-insurance service center connects directly with many insurers.
Highlights
- International Medical Center opened June 2025
- 24-hour IMC hotline and email
- Passport accepted to issue a temporary patient card
Departments and doctors
Flagship specialty
Hepatobiliary and Pancreatic Surgery
【Department Name】Hepatobiliary and Pancreatic Surgery 【Department Overview】The Department of Hepatobiliary and Pancreatic Surgery of Zhongshan Hospital Affiliated to Xiamen University is a National Key Specialty and one of the first batch of Fujian Provincial Clinical Key Specialties. It is the first hepatobiliary and pancreatic surgery department in southwestern Fujian; the department has established subspecialties including liver, biliary tract, and pancreatic subspecialties, as well as an interventional minimally invasive subspecialty; the Department of Hepatobiliary and Pancreatic Surgery has established the “Fujian Provincial Key Laboratory of Chronic Liver Disease and Liver Cancer” and the “Xiamen Key Laboratory of Translational Medicine for Hepatobiliary and Pancreatic Tumors.” It currently has two wards, 96 beds, 14,000 outpatient visits annually, 4,000 inpatient admissions annually, and more than 2,000 operations annually. The department focuses intensively on the diagnosis and treatment of hepatobiliary and pancreatic diseases, develops a multisubspecialty system, integrates minimally invasive diagnosis and treatment with research translation, implements the ERAS concept of enhanced recovery, and has filled regional gaps with multiple technologies, placing its overall strength in the first echelon of hepatobiliary and pancreatic specialties in China. 【Scope of Diagnosis and Treatment】1. Screening, comprehensive diagnosis, and treatment of liver diseases such as benign and malignant liver tumors, chronic liver disease, and liver cancer; 2. Minimally invasive treatment and standardized postoperative management of biliary system diseases such as gallstones, biliary tract tumors, and biliary tract malformations; 3. Precision surgical treatment of pancreatic diseases such as pancreatic cancer, benign pancreatic masses, and pancreatic inflammation; 4. Treatment of complex, difficult, and critically ill hepatobiliary and pancreatic cases, high-difficulty Grade III and IV surgeries, and translational tumor treatment; 5. Early screening of hepatobiliary and pancreatic diseases, minimally invasive interventional treatment, enhanced recovery, and standardized nutritional management. 【Specialized Technologies】In 2003, the department successfully performed liver transplantation. In 2010, it completed the first ex vivo liver resection with autologous liver transplantation in Fujian Province. In 2014, it completed the first associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in southwestern Fujian. In 2017, it completed the first totally laparoscopic pancreaticoduodenectomy in southwestern Fujian. Since 2022, it has routinely performed Da Vinci robotic pancreaticoduodenectomy. The volume and quality of laparoscopic minimally invasive liver cancer surgery, laparoscopic and choledochoscopic minimally invasive biliary surgery, and laparoscopic pancreatic surgery all rank among the highest in the province. The department’s diagnostic and treatment technologies are leading in the province and top-ranked in the region. It routinely performs various laparoscopic and Da Vinci robotic minimally invasive hepatobiliary and pancreatic surgeries and is proficient in high-difficulty procedures such as ex vivo liver resection with autologous liver transplantation, ALPPS two-stage hepatectomy, and totally laparoscopic pancreaticoduodenectomy. The department also routinely performs precision interventional treatment for liver cancer (TACE/HAIC) and yttrium-90 microsphere selective internal radiation therapy (Y90-SIRT). More than 85% of the department’s procedures are difficult Grade III and IV surgeries. It comprehensively implements minimally invasive, precision, and individualized diagnosis and treatment and the ERAS enhanced recovery model, with the volume and quality of minimally invasive surgery ranking among the highest in the province. 【Expert Team】The department currently has 62 medical and nursing personnel, including 22 physicians, of whom 8 are chief physicians; 13 hold doctoral degrees, and 3 have overseas study experience. It has 7 master’s and doctoral supervisors, 2 experts receiving the State Council Special Allowance, 2 Fujian Province “Hundreds, Thousands and Tens of Thousands” talents, 2 Xiamen outstanding talents, 1 Xiamen young innovative talent, and 1 Xiamen high-level Category B talent and 1 Category C talent. 【Research Achievements】Senior professional title holders account for 65% of the research team, and personnel with doctoral degrees account for 75%. The department has always been committed to high-level scientific research and innovation. It has undertaken more than 50 important research projects, including 16 National Natural Science Foundation of China projects, 4 subprojects of the “973 Program,” 2 subprojects of National Major Special Projects, 1 subproject of the National Major Scientific Instrument Special Project, and multiple provincial- and ministerial-level projects. Department members have published more than 100 high-level academic papers as first or corresponding authors. The department has received 1 second prize of the Fujian Provincial Science and Technology Progress Award and 1 third prize of the Fujian Medical Science and Technology Award, and has won the Xiamen Science and Technology Progress Award multiple times, including 2 first prizes, 2 second prizes, and 2 third prizes. It has obtained 4 Chinese invention patents and more than 20 utility model patents. 【Department Location】Hepatobiliary and Pancreatic Surgery Ward 1 Building 7, 15th Floor Hepatobiliary and Pancreatic Surgery Ward 2 Building 7, 16th Floor 【Contact Telephone】Area 1 Nurses’ Station 2291516 Doctors’ Office 2291517 Area 2 Nurses’ Station 2291603 Doctors’ Office 2291609 1. Academician Chen Xiaoping Guidance Platform 2. Member institution of the China Hepatobiliary and Pancreatic Specialty Alliance 3. Undertaking institution for National Major Science and Technology Special Projects 4. Academician Chen Xiaoping Famous Surgeon Studio 5. Xiamen Key Laboratory of Translational Medicine for Digestive System Tumors 6. Demonstration base of a founding institution of the National Alliance for Enhanced Recovery After Surgery (Gastrointestinal) 7. Xiamen Medical Leading Discipline Development Project 8. Fujian Provincial Standard ERAS Ward for Surgery 9. Standard ERAS Ward for Liver Surgery 10. Fujian Provincial Key Laboratory of Chronic Liver Disease and Liver Cancer 11. National Clinical Key Specialty General Surgery--Hepatobiliary and Pancreatic Surgery 12. Demonstration Ward for Nutritional Management in Enhanced Recovery After Surgery 13. Academician Dong Jiahong Famous Physician Studio 14. Fujian Provincial Clinical Key Specialty General Surgery (Hepatobiliary and Pancreatic Surgery) 15. Fujian Provincial Clinical Key Specialty Hepatobiliary Surgery 16. National Clinical Key Specialty General Surgery--Retroperitoneal Tumor Surgery 17. Demonstration institution for pain-free ward development 18. Institution advancing the liver cancer prevention and control system 19. Demonstration Ward for Implementation of Enhanced Recovery After Surgery 20. One of the first batch of leading disciplines in Xiamen
Doctors
Doctor profiles: 4
Showing 1–4
周剑寅
Chief Physician
Clinical interests
✔ Main focus: hepatobiliary, pancreatic, and splenic diseases and precision surgical treatment ✔ Distinctive expertise: hepatobiliary, pancreatic, and splenic surgery and minimally invasive, personalized tumor treatment
方钦亮
Associate Chief Physician
Clinical interests
✔ Main focus: precise diagnosis and treatment of common hepatobiliary and pancreatic diseases, gallstones, liver cancer, bile duct cancer, and pancreatic cancer ✔ Distinctive expertise: various minimally invasive hepatobiliary surgeries, enhanced recovery after surgery (ERAS), primary suture of bile duct stones, and radiofrequency ablation of liver tumors
Read more
✔ Main focus: precise diagnosis and treatment of common hepatobiliary and pancreatic diseases, gallstones, liver cancer, bile duct cancer, and pancreatic cancer ✔ Distinctive expertise: various minimally invasive hepatobiliary surgeries, enhanced recovery after surgery (ERAS), primary suture of bile duct stones, and radiofrequency ablation of liver tumors
王效民
Chief Physician
黄学峰
Associate Chief Physician
Clinical interests
Specializes in precision treatment of malignant liver tumors; minimally invasive treatment of benign gallbladder diseases such as gallbladder polyps and gallstones; and minimally invasive treatment of bile duct stones.